These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 24702227)

  • 21. Expression of keratinocyte growth factor and its receptor in noncholesteatomatous and cholesteatomatous chronic otitis media.
    Yamamoto-Fukuda T; Takahashi H; Terakado M; Hishikawa Y; Koji T
    Otol Neurotol; 2010 Jul; 31(5):745-51. PubMed ID: 20502381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the epidermal growth factor system in human middle ear cholesteatoma.
    Thorup MB; Munk M; Poulsen SS; Gaihede M; Nexo E; Sorensen BS; Ovesen T
    Acta Otolaryngol; 2014 Feb; 134(2):124-34. PubMed ID: 24256036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteoclastic activity in chronic otitis media with cholesteatoma-related bone destruction.
    Özgür A; Yemiş T; Başbulut E; Turgut NF; Özdemir D; Akgül G; Mehel DM; Çelebi M
    J Laryngol Otol; 2021 Oct; 135(10):879-882. PubMed ID: 34348812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of differences in facial nerve dehiscence and ossicular injury in chronic otitis media and cholesteatoma.
    Choi SA; Kang HM; Byun JY; Park MS; Yeo SG
    Acta Otolaryngol; 2014 May; 134(5):455-61. PubMed ID: 24702225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The functional and anatomical results of the canal wall down tympanoplasty in extensive cholesteatoma.
    Aslan Felek S; Islam A; Celik H; Demirci M; Samim E; Kose SK
    Acta Otolaryngol; 2009 Dec; 129(12):1388-94. PubMed ID: 19922086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A retrospective study on cholesteatoma otitis media coexisted with cholesterol granuloma].
    Gong S; Bai G; Wang J
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Aug; 36(4):289-91. PubMed ID: 12761999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteoclast stimulating and differentiating factors in human cholesteatoma.
    Hamzei M; Ventriglia G; Hagnia M; Antonopolous A; Bernal-Sprekelsen M; Dazert S; Hildmann H; Sudhoff H
    Laryngoscope; 2003 Mar; 113(3):436-42. PubMed ID: 12616193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Condition of the anterior part of the middle ear cleft in acquired cholesteatoma.
    Albera R; Nadalin J; Garzaro M; Lacilla M; Pecorari G; Canale A
    Acta Otolaryngol; 2008 Jun; 128(6):634-8. PubMed ID: 18568496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mast cells positive for cluster of differentiation 117 protein: are they players or conductor in the orchestra of cholesteatoma?
    Calli AO; Sari A; Cakalagaoglu F; Altinboga AA; Calli C; Oncel S
    J Laryngol Otol; 2012 Aug; 126(8):775-9. PubMed ID: 22697111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of TIM-1 and TIM-3 in spleen mononuclear cells and their role in Th1 polarization in primary immune thrombocytopenia patients].
    Zhang XM; Shan NN; Hu Y; Wang X
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jul; 34(7):614-7. PubMed ID: 23906457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical assessment of patients with chronic otitis media with cholesteatoma].
    Tekin M; Osma U; Meriç F; Topçu I
    Kulak Burun Bogaz Ihtis Derg; 2002; 9(4):263-6. PubMed ID: 12422080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of C-type lectin receptors by subsets of dendritic cells in human skin.
    Ebner S; Ehammer Z; Holzmann S; Schwingshackl P; Forstner M; Stoitzner P; Huemer GM; Fritsch P; Romani N
    Int Immunol; 2004 Jun; 16(6):877-87. PubMed ID: 15113774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of Ki-67 expression in recurrent cases of cholesteatoma].
    Sanli A; Tezer I; Paksoy M; Aydin S; Hardal U; Ozdemir NB
    Kulak Burun Bogaz Ihtis Derg; 2007; 17(2):65-9. PubMed ID: 17527055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Air-bone gap and hearing impairment level predictive value in preoperative assessment of cholesteatoma localization in the tympanic cavity.
    Durko M
    Otolaryngol Pol; 2004; 58(1):73-7. PubMed ID: 15101263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression and significance of Tim-3 on peripheral blood monocytes in patients with chronic hepatitis B].
    Gao X; Li C; Pan X; Li L; Fu J; Yao W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jul; 29(7):739-43. PubMed ID: 23837986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysgeusia and cholesteatoma.
    Kim HH; Kim EU; Wilson DF
    Am J Otolaryngol; 2006; 27(5):353-4. PubMed ID: 16935184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of recurrent and primary acquired cholesteatoma with echo-planar diffusion-weighted magnetic resonance imaging.
    Evlice A; Tarkan Ö; Kiroğlu M; Biçakci K; Özdemir S; Tuncer Ü; Çekiç E
    J Laryngol Otol; 2012 Jul; 126(7):670-6. PubMed ID: 22583684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on distribution of α1-antitrypsin, lysozyme, lactoferrin, and mast cell enzymes in diseased middle ear mucosa.
    Kim JS; Yoon YJ; Lee EJ
    Acta Otolaryngol; 2014 Aug; 134(8):791-5. PubMed ID: 24931056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anatomical and functional results of open cavity tympanomastoidectomy].
    Yalçın Y; Uğur O; Cukurova I; Gümüşsoy M
    Kulak Burun Bogaz Ihtis Derg; 2012; 22(4):207-13. PubMed ID: 22770255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors for sensorineural hearing loss in patients with tubotympanic otitis, cholesteatoma, and tympanic membrane retractions.
    Jesic SD; Jotic AD; Babic BB
    Otol Neurotol; 2012 Aug; 33(6):934-40. PubMed ID: 22722145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.